Dr Hannah Wardill’s research focuses on easing pain after cancer treatment and long-term cancer survivorship and quality of life
One in five people with myeloma (a type of blood cancer) treated with the highly-effective drug bortezomib are forced to stop treatment due to chronic pain. This project aims to understand how changes in gut bacteria caused by bortezomib contribute to pain, and identify new ways to control pain and improve outcomes for people with myeloma.
Dr Wardill is also establishing a faecal microbiota transplant (FMT – or stool transplant) service for people with blood cancers to help replenish their good gut bacteria that are damaged during treatment. It is hoped that FMT will rid them of their debilitating side effects and provide an additional line of support for people undergoing cancer treatment.
“I am so grateful to the supporters of The Hospital Research Foundation Group for helping me find answers for patients in this sometimes forgotten area of healthcare,” said Dr Hannah Wardill.
Dr Wardill’s ground-breaking South Australian-based project received the funding after a competitive grant application process.
The funding has been made possible thanks to The Hospital Research Foundation Group’s generous donors, fundraisers from events like The Longest Table, corporate partners and ticket buyers in the Hospital Research Foundation Home Lottery.
You can help in the fight cancer by hosting a Longest Table in 2023!
